ReviewBritish journal of clinical pharmacology2003
Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part II: Efficacy and safety.
Review in British journal of clinical pharmacology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 1 synthesis or guideline pooled it, 156 citations in OpenAlex.
- Chinese herbal medicines for hypercholesterolemia.The Cochrane database of systematic reviews · 2011Pooled it
- Toxicological evaluation of Lagerstroemia speciosa (L.) Martyn and Lagerstroemia tomentosa C.Presl extracts using a liver organ-on-a-chip system.Scientific reports · 2026Article
- Coal-Derived Humic Substances: Insight into Chemical Structure Parameters and Biomedical Properties.Molecules (Basel, Switzerland) · 2024Article
- A public survey of traditional, complementary and integrative medicine use during the COVID-19 outbreak in Hong Kong.PloS one · 2021Article
- Simultaneous quantification of six indicator compounds in Wen-Qing-Yin by high-performance liquid chromatography-diode array detection.Journal of food and drug analysis · 2019Article
- Prevalence and correlates of herbal medicine use among type 2 diabetic patients in Teaching Hospital in Ethiopia: a cross-sectional study.BMC complementary and alternative medicine · 2018Article
- An unusual presentation of chronic cyanide toxicity from self-prescribed apricot kernel extract.BMJ case reports · 2017Article
- Natural health product-drug interaction tool: A scoping review.Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC · 2016Article
- PHARMACEUTICAL EVALUATION AND TOXICOLOGICAL QUANTIFICATION OF HEAVY METALS AND ADULTERATED ALLOPATHIC CONTENTS IN RAW AND FINISHED DOSAGE FORM OF ANTIHYPERTENSIVE HERBAL PRODUCTS.African journal of traditional, complementary, and alternative medicines : AJTCAM · 2016Article
- Too little, too late: ineffective regulation of dietary supplements in the United States.American journal of public health · 2015Article
- Concomitant intake of quercetin with a grain-based diet acutely lowers postprandial plasma glucose and lipid concentrations in pigs.BioMed research international · 2014Article
- Complementary and alternative medicine use among diabetic patients in Africa: a Kenyan perspective.The Pan African medical journal · 2013Article
- Tracking and treating activated T cells.Journal of drug delivery science and technology · 2013Article
- Randomised, double blind, placebo-controlled trial of echinacea supplementation in air travellers.Evidence-based complementary and alternative medicine : eCAM · 2012Article
- The ethics of traditional chinese and Western herbal medicine research: views of researchers and human ethics committees in australia.Evidence-based complementary and alternative medicine : eCAM · 2011Article
- Inhibitory effects of ginger (Zingiber officinale Roscoe) essential oil on leukocyte migration in vivo and in vitro.Journal of natural medicines · 2011Article
- Ethical Considerations for Acupuncture and Chinese Herbal Medicine Clinical Trials: A Cross-cultural Perspective.Evidence-based complementary and alternative medicine : eCAM · 2010Article
- Bromelain treatment reduces CD25 expression on activated CD4+ T cells in vitro.International immunopharmacology · 2009Article
- Homoeopathic and herbal prescribing in general practice in Scotland.British journal of clinical pharmacology · 2006Article
- Cytotoxicity of clove (Syzygium aromaticum) oil and its major components to human skin cells.Cell proliferation · 2006Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This is the second of two papers which review issues concerning complementary medicines. The first reviewed the extent of use of complementary medicines, and issues related to the regulation and pharmaceutical quality of these products; the second considers evidence for the efficacy of several well-known complementary medicines, and discusses complementary-medicines pharmacovigilance. The term complementary medicines describes a range of pharmaceutical-type preparations, including herbal medicines, homoeopathic remedies, essential oils and dietary supplements, which mainly sit outside conventional medicine. The use of complementary medicines is a popular healthcare approach in the UK, and there are signs that the use of such products is continuing to increase. Patients and the public use complementary medicines for health maintenance, for the treatment or prevention of minor ailments, and also for serious, chronic illnesses. There is a growing body of evidence from randomized controlled trials and systematic reviews to support the efficacy of certain herbal extracts and dietary supplements in particular conditions. However, many other preparations remain untested. Strictly speaking, evidence of efficacy (and safety) for herbal medicines should be considered to be extract specific. Pharmacovigilance for complementary medicines is in its infancy. Data are lacking in several areas relevant to safety. Standard pharmacovigilance tools have additional limitations when applied to investigating safety concerns with complementary medicines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.